Insider Trading Alert - OPK, WDAY And CHD Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 24, 2014, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $820.00 to $144,690,560.42.

Highlighted Stocks Traded by Insiders:

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 30,800 shares at $9.46 on March 24, 2014. Following this transaction, the CEO & Chairman owned 139.7 million shares meaning that the stake was reduced by 0.02% with the 30,800-share transaction.

The shares most recently traded at $9.45, down $0.01, or 0.07% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 46,730
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 46,730
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 46,730

The average volume for Opko Health has been 3.1 million shares per day over the past 30 days. Opko Health has a market cap of $3.9 billion and is part of the health care sector and health services industry. Shares are up 10.07% year-to-date as of the close of trading on Monday.

Opko Health, Inc., a biopharmaceutical and diagnostics company, is engaged in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Workday (WDAY) - FREE Research Report

Still George J Jr who is Director at Workday sold 8,334 shares at $101.05 on March 24, 2014. Following this transaction, the Director owned 146,666 shares meaning that the stake was reduced by 5.38% with the 8,334-share transaction.

The shares most recently traded at $96.32, down $4.73, or 4.91% since the insider transaction. Historical insider transactions for Workday go as follows:

  • 4-Week # shares sold: 125,000
  • 12-Week # shares sold: 125,000
  • 24-Week # shares sold: 250,000

The average volume for Workday has been 1.5 million shares per day over the past 30 days. Workday has a market cap of $7.6 billion and is part of the technology sector and computer software & services industry. Shares are up 14.94% year-to-date as of the close of trading on Monday.

Workday, Inc. provides enterprise cloud-based applications for enterprises in the United States and internationally. It offers applications for customers to manage critical business functions that enable them to optimize their financial and human capital resources. Currently there are 11 analysts that rate Workday a buy, no analysts rate it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WDAY - FREE

TheStreet Quant Ratings rates Workday as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and feeble growth in its earnings per share. Get the full Workday Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Church & Dwight Company (CHD) - FREE Research Report

Craigie James who is Chairman and CEO at Church & Dwight Company bought 3,660 shares at $54.64 on March 24, 2014. Following this transaction, the Chairman and CEO owned 900 shares meaning that the stake was reduced by 132.61% with the 3,660-share transaction.

The shares most recently traded at $68.32, up $13.68, or 20.03% since the insider transaction. Historical insider transactions for Church & Dwight Company go as follows:

  • 24-Week # shares bought: 7,718

The average volume for Church & Dwight Company has been 741,500 shares per day over the past 30 days. Church & Dwight Company has a market cap of $9.3 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 2.46% year-to-date as of the close of trading on Monday.

Church & Dwight Co., Inc., together with its subsidiaries, develops, manufactures, and markets a range of household, personal care, and specialty products under various brand names in the United States and internationally. The stock currently has a dividend yield of 1.81%. The company has a P/E ratio of 24.6. Currently there are 9 analysts that rate Church & Dwight Company a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHD - FREE

TheStreet Quant Ratings rates Church & Dwight Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Church & Dwight Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists